<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03052660</url>
  </required_header>
  <id_info>
    <org_study_id>16-115</org_study_id>
    <nct_id>NCT03052660</nct_id>
  </id_info>
  <brief_title>Impact of Preoperative Midazolam on Outcome of Elderly Patients</brief_title>
  <acronym>I-PROMOTE</acronym>
  <official_title>Impact of Preoperative Midazolam on Outcome of Elderly Patients: a Multicentre Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to assess, if placebo compared to preoperative administration of midazolam in elderly
      patients is equal in regard to the global postoperative patient satisfaction
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Generalised premedication with benzodiazepines in all surgical patients has become
      questionable, regarding the risk-benefit assessment and the lack of evidence for this
      practice. Particularly, in elderly patients (≥65 years), a higher risk for adverse events is
      described.

      Patients will be randomly assigned to one of the following two study groups. Preoperatively,
      group 1 will receive midazolam and group 2 will receive placebo.

      Anaesthesia will be performed according to the clinical routine.

      All possible side effects are described in the SmPC for midazolam. For the placebo-group, we
      do not expect any harm, as in the case of strong preoperative anxiety or agitation,
      additional midazolam application may occur on behalf of the attending anaesthesist at any
      time.

      The sample size was calculated based on detecting a minimum of 5 unit difference in the
      primary outcome variable overall patient satisfaction measured with the EVAN-G. Setting a
      type 1 error of 0.05, a power of 0.8 and assuming the standard deviation of EVAN-G to be 14
      units, 248 patients per group are needed to detect a 5 unit difference.

      Considering a drop-out of 10% and a screening failure of 10%, we decided to include 614
      patients in total.

      The hypothesis of the study is that global patient satisfaction after surgery in elderly
      patients is similar after preoperative placebo application compared to midazolam application.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Global patient satisfaction on the first postoperative day</measure>
    <time_frame>on the first postoperative day (1 day)</time_frame>
    <description>measured with the EVAN-G questionnaire on the first postoperative day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive testing</measure>
    <time_frame>preoperative, day 1 and day 30 after surgery (31 days)</time_frame>
    <description>Measured by the short blessed test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium testing</measure>
    <time_frame>preoperative, day 1 after surgery (2 days)</time_frame>
    <description>Measured by Confusion Assessment Method (CAM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preoperative anxiety</measure>
    <time_frame>preoperatively (1 day)</time_frame>
    <description>Measured by Amsterdam Preoperative Anxiety and Information Scale (APAIS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>preoperative and day 30 after surgery (31 days)</time_frame>
    <description>Measured by the health-related quality of life assessment EQ-5D-5L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities of daily living</measure>
    <time_frame>preoperative and day 30 after surgery (31 days)</time_frame>
    <description>Measured by Instrumental Activities of Daily Living scale (IADL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perception of pain, well-being, and sleeping</measure>
    <time_frame>preoperative until first postoperative day (3 days)</time_frame>
    <description>Self-reported by visual analogue scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with adverse events and serious adverse events</measure>
    <time_frame>surgery and first postoperative day (2 days)</time_frame>
    <description>Review of medical charts and patient interview</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient cooperation</measure>
    <time_frame>surgery day (1 day)</time_frame>
    <description>Self-reported by visual analogue scale (VAS) by the attending anesthetist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anaesthesia related data</measure>
    <time_frame>surgery day (1 day)</time_frame>
    <description>Anesthesia drugs, type of anesthesia, duration, extubation-time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery related data</measure>
    <time_frame>surgery day (1 day)</time_frame>
    <description>Duration and kind of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue benzodiazepine application</measure>
    <time_frame>surgery day (1 day)</time_frame>
    <description>assessment of additional requirement of midazolam in the operating area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients vital data</measure>
    <time_frame>surgery day (1 day)</time_frame>
    <description>Measurement of SpO2, RRsys, HR on arrival in the operating room and at the end of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Patient chart review and telephone interview after discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse events</measure>
    <time_frame>30 days</time_frame>
    <description>Assessment of postoperative major adverse cardiovascular and cerebral events by patient chart review and telephone interview after discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>on postoperative day 30 (1 day)</time_frame>
    <description>Patient chart review</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive care unit length of stay</measure>
    <time_frame>on postoperative day 30 (1 day)</time_frame>
    <description>Patient chart review</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">614</enrollment>
  <condition>Preanesthetic Medication</condition>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Midazolam, 3.75 mg , oral, once, 30-45 minutes before surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo, oral, once, 30-45 minutes before surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Oral administration preoperatively</description>
    <arm_group_label>Midazolam</arm_group_label>
    <other_name>Dormicum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo oral capsule</intervention_name>
    <description>Oral administration preoperatively</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 1. Only legally competent patients

          2. Written informed consent prior to study participation

          3. 65-80 years

          4. Elective surgery

          5. Expected surgery duration ≥ 30 minutes

          6. Planned general or combined regional and general anaesthesia

          7. Planned extubation at the end of surgery

        Exclusion Criteria:

          1. Age &gt; 80 years

          2. Age &lt; 65 years

          3. Non-fluency in German language

          4. Alcohol and/ or drugs abuse

          5. Chronic benzodiazepine treatment

          6. Intracranial surgery

          7. Local and stand by anaesthesia or solely regional anaesthesia

          8. Monitored anaesthesia care

          9. Cardiac surgery

         10. Ambulatory surgery

         11. Repeated surgery

         12. Contraindications for benzodiazepine application (e.g. sleep apnoea syndrome, severe
             chronic obstructive pulmonary disease, allergy)

         13. Allergy against any component of the Placebo (lactose monohydrate, cellulose powder,
             magnesium stearate, microcrystalline cellulose) or investigational drug (midazolam,
             lactose) or the capsules (gelatine, E171 titanium dioxide, E132 indigotine).

         14. Expected benzodiazepine requirement after surgery

         15. Expected continuous mandatory ventilation after surgery

         16. Patients who explicitly request anxiolytic premedication

         17. Patients with severe neurological or psychiatric disorders

         18. Refusal of study participation by the patient

         19. Parallel participation in interventional clinical studies within the last 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Coburn, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology, University Hospital Aachen, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Coburn, Professor</last_name>
    <phone>+49241-8088179</phone>
    <email>anaesthesiologie@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ana Stevanovic, MD</last_name>
    <phone>+49241-8088179</phone>
    <email>anaesthesiologie@ukaachen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology, University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana Stevanovic, MD</last_name>
      <phone>+4924180-88179</phone>
      <email>anaesthesiologie@ukaachen.de</email>
    </contact>
    <contact_backup>
      <last_name>Mark Coburn, Professor</last_name>
      <phone>+4924180-88179</phone>
      <email>anaesthesiologie@ukaachen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Ana Stevanovic, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Coburn, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <state>NRW</state>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin Söhle, Professor</last_name>
    </contact>
    <contact_backup>
      <last_name>Maria Wittmann, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Martin Söhle, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Wittmann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Anästhesiologie, Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Dusseldorf</city>
        <state>NRW</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Kienbaum, Professor</last_name>
    </contact>
    <contact_backup>
      <last_name>Maximilian Schäfer, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Peter Kienbaum, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maximilian Schäfer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marien-Hospital Herne</name>
      <address>
        <city>Herne</city>
        <zip>44625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Petra Bischoff, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Petra Bischoff, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Urs-Giger Pabst, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jens Peter Hölzen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florian Roghmann, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rainer Wirth, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Magdeburg A.ö.R.</name>
      <address>
        <city>Magdeburg</city>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Moritz Kretzschmar, Dr. Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Moritz Kretzschmar, Dr. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jens Schreiber, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>LMU München</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick Möhnle, PD Dr.</last_name>
    </contact>
    <investigator>
      <last_name>Patrick Möhnle, PD Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Josef Briegel, Prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Saller, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kreiskliniken Reutlingen, Klinikum am steinenberg</name>
      <address>
        <city>Reutlingen</city>
        <zip>72764</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Friedrich K. Pühringer, Prof.</last_name>
    </contact>
    <investigator>
      <last_name>Friedrich K. Pühringer, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Rex, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hansjörg Haas, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Tübingen</name>
      <address>
        <city>Tubingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Helene Häberle, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Stefanie Prohaska, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Helene Häberle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefanie Prohaska, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Berthold Drexler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Auquier P, Pernoud N, Bruder N, Simeoni MC, Auffray JP, Colavolpe C, François G, Gouin F, Manelli JC, Martin C, Sapin C, Blache JL. Development and validation of a perioperative satisfaction questionnaire. Anesthesiology. 2005 Jun;102(6):1116-23.</citation>
    <PMID>15915023</PMID>
  </results_reference>
  <results_reference>
    <citation>American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults. American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. J Am Geriatr Soc. 2015 Jan;63(1):142-50. doi: 10.1111/jgs.13281. Epub 2014 Dec 12.</citation>
    <PMID>25495432</PMID>
  </results_reference>
  <results_reference>
    <citation>Maurice-Szamburski A, Auquier P, Viarre-Oreal V, Cuvillon P, Carles M, Ripart J, Honore S, Triglia T, Loundou A, Leone M, Bruder N; PremedX Study Investigators. Effect of sedative premedication on patient experience after general anesthesia: a randomized clinical trial. JAMA. 2015 Mar 3;313(9):916-25. doi: 10.1001/jama.2015.1108.</citation>
    <PMID>25734733</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2017</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 14, 2017</study_first_posted>
  <last_update_submitted>September 26, 2017</last_update_submitted>
  <last_update_submitted_qc>September 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Midazolam</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Clinical trial</keyword>
  <keyword>Patient Satisfaction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

